Thereza Soares

Dr. Thereza Soares

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2020 in The Journal of Chemical Physics
Verified
Journal Article
Open access
PDF file
EAE. Aprà
E. Aprà
EBE. J. Bylaska
E. J. Bylaska
WJW. A. de Jong
W. A. de Jong
NGN. Govind
N. Govind
KKKarol Kowalski
Karol Kowalski
RHR. J. Harrison
R. J. Harrison
Specialized computational chemistry packages have permanently reshaped the landscape of chemical and materials science by providing tools to support and guide experimental efforts and for the prediction of atomistic and electronic properties. In this regard, electronic structure packages have played a special role by using first-principle-driven methodologies to model complex chemical and materials processes. Over the past few decades, the rapid development of computing technologies and the tremendous increase in computational power have offered a unique chance to study complex transformations using sophisticated and predictive many-body techniques that describe correlated behavior of electrons in molecular and condensed phase systems at different levels of theory. In enabling these simulations, novel parallel algorithms have been able to take advantage of computational resources to address the polynomial scaling of electronic structure methods. In this paper, we briefly review the NWChem computational chemistry suite, including its history, design principles, parallel tools, current capabilities, outreach, and outlook.

1 April 2005 in European Biophysics Journal
Verified
Journal Article
Closed access
PDF file
COChris Oostenbrink
Chris Oostenbrink
TSThereza Soares
Thereza Soares
NVNico van der Vegt
Nico van der Vegt
WGWilfred F. van Gunsteren
Wilfred F. van Gunsteren

6 August 2012 in RSC Advances
Verified
Journal Article
Closed access
PDF file
IVIane B. Vasconcelos
Iane B. Vasconcelos
TSTeresinha G. da Silva
Teresinha G. da Silva
GMGardenia C. G. Militão
Gardenia C. G. Militão
TSThereza Soares
Thereza Soares
NRNailton M. Rodrigues
Nailton M. Rodrigues
SJSeverino A. Junior
Severino A. Junior
Metal–organic frameworks are emerging as a powerful platform for the delivery and controlled release of several drug molecules. Herein, we report the incorporation of the anti-cancer drug doxorubicin into the zeolitic imidazolate framework (ZIF-8) with high-load and progressive release. Adsorption measurements show that doxorubicin is incorporated into ZIF-8 with a load of 0.049 g doxorubicin g−1 dehydrated ZIF-8. Doxorubicin is released in a highly controlled and progressive fashion with 66% of the drug released after 30 days. We also characterize the antitumoral potential and cytotoxicity of the doxorubicin-ZIF-8 (DOXO-ZIF-8) complex towards the mucoepidermoid carcinoma of human lung (NCI-H292), human colorectal adenocarcinoma (HT-29), and human promyelocytic leukemia (HL-60) cell lines. It is shown that the complex doxorubicin-ZIF-8 exhibits lower cytotoxicity than pure doxorubicin for the tested cells, possibly due to the slower release of the incorporated drug. Furthermore, host–guest interactions have been addressed from a microscopic perspective through molecular docking simulations. In conjunction with our experimental characterization, the calculations suggest that doxorubicin binds preferentially to the surface rather than into the pores of ZIF-8, whose entry diameter is at least half the size of the shortest axis of the drug. These findings are also consistent with high-resolution X-ray crystallography and NMR spectroscopy studies of ZIF-8 which shows that this framework is very rigid under constant pressure in contrast to previous experimental and theoretical studies of ZIF-8 under gas pressure.

15 March 2005 in Journal of Computational Chemistry
Verified
Journal Article
Closed access
PDF file
TSThereza Soares
Thereza Soares
PHPhilippe H. Hünenberger
Philippe H. Hünenberger
MKMika A. Kastenholz
Mika A. Kastenholz
VKVincent Kräutler
Vincent Kräutler
TLThomas Lenz
Thomas Lenz
WGWilfred F. van Gunsteren
Wilfred F. van Gunsteren

28 November 2022 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
TSThereza Soares
Thereza Soares
ANAriane Nunes-Alves
Ariane Nunes-Alves
Angelica MazzolariAngelica Mazzolari
Angelica Mazzolari
FRFiorella Ruggiu
Fiorella Ruggiu
Guowei WeiGuowei Wei
Guowei Wei
KMKenneth Merz
Kenneth Merz

6 June 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Laura SilvaLaura Silva
Laura Silva
GHGabriel Costa Alverni Da Hora
Gabriel Costa Alverni Da Hora
TSThereza Soares
Thereza Soares
MBMartin Saxtorph Bojer
Martin Saxtorph Bojer
HIHanne Ingmer
Hanne Ingmer
DTD. S. Trentin
D. S. Trentin
Staphylococcus aureus is an opportunistic pathogen related to a variety of life-threatening infections but for which antimicrobial resistance is liming the treatment options. We report here that myricetin, but not its glycosylated form, can remarkably decrease the production of several S. aureus virulence factors, including adhesion, biofilm formation, hemolysis and staphyloxanthin production, without interfering with growth. Myricetin affects both surface proteins and secreted proteins which indicate that its action is unrelated to inhibition of the agr quorum sensing system. Analysis of virulence related gene expression and computational simulations of pivotal proteins involved in pathogenesis demonstrate that myricetin downregulates the saeR global regulator and interacts with sortase A and α-hemolysin. Furthermore, Myr confers a significant degree of protection against staphylococcal infection in the Galleria mellonella model. The present findings reveal the potential of Myr as an alternative multi-target antivirulence candidate to control S. aureus pathogenicity.